Neuroscience Clinical Research
Preparing for Growth in Neurodegenerative Treatment Opportunities
Advances in the understanding of neurology have led to significant progress in the development of treatments for neurodegenerative disorders. While patient enrollment and retention for clinical trials in this field can be challenging, CROs with the right expertise, tools and passion can enable sponsors to implement successful, cost-effective studies that minimize site and patient burden.
See how innovative thinking makes it possible for PPD to enable you to bring your breakthrough therapies for neurodegenerative diseases to market as quickly, safely and cost-effectively as possible.
In the past five years, we have supported:
Want to Learn More?
Rare Neurological Disorders
Ingenuity for the Evolving Neuroscience Clinical Trial Landscape
In neuroscience studies, it’s critical to anticipate how patients, investigators, regulatory bodies and payors will respond to study drugs—and be prepared to nimbly pivot your study strategy. By gathering insights and data through trial simulators and patient registries such as Synexus HealthyMinds, PPD has the proven ability to anticipate challenges and guide your study through these complexities. And investments in solutions and teams that work to improve neuroscience study quality and certainty add value for you and your patients.
Clinical Trial Simulator
Start your trial off on the right foot by running a clinical trial simulator to identify potential gaps in your program from the start. We work with you to use these insights to guide the selection of design parameters for clinical trials in indications like Alzheimer’s and Parkinson’s diseases.
Training for Health Care Practitioners
To meet the increasing number of health care professionals needed in neuroscience, we provide access to SiteCoach, a platform that offers customized and robust training, coaching and support to health care practitioners new to clinical research.
Dedicated Patient Enrollment Solution
Access our robust and growing Accelerated Enrollment Solutions (AES) patient database, which includes:
- Thousands of contracted patients
- More than 20 million pre-screened candidates
- 100 million households with individuals who have opted in
In addition to our own global, wholly owned network of sites, we also provide connection to an extended traditional site network and act as a liaison with all trial vendors.
Decentralized Clinical Trial Technology and Patient-centric Solutions
Ease the burden on clinical trial participants and their caregivers with decentralized clinical trial (DCT) advancements developed specifically for neuroscience research. These solutions include:
- Direct-to-patient models
- Remote eConsent
- Home health care services